logo
Select company
Select metric
$ 1.44MNet Cash Flow - Change in Cash & Cash Equivalents
VS
Market
54
Sector
60
Industry
63
History
63
$ 0.23Close
$ 0.19 - $ 0.44 52-Week Range
Ticker Information

Ticker

NWBO

Company Name

NORTHWEST BIOTHERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

OTC

NORTHWEST BIOTHERAPEUTICS INC - Net Cash Flow - Change in Cash & Cash Equivalents Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

NWBO - CF - Chg. Cash Historical data
DateNet Cash Flow - Change in Cash & Cash Equivalents
6/30/2025$ 1.44M
3/31/2025$ 301K
12/31/2024$ 49K
9/30/2024$ -3.16M
6/30/2024$ 1.46M
3/31/2024$ -3.71M
12/31/2023$ -4.84M
9/30/2023$ -3.33M
6/30/2023$ -3.41M
3/31/2023$ -772K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • NORTHWEST BIOTHERAPEUTICS INC's latest trailing twelve months (TTM) CF - Chg. Cash stands at $ 7.28M.
  • Over the past 5 years, NORTHWEST BIOTHERAPEUTICS INC's average CF - Chg. Cash has been $ 157.4K.
  • The median CF - Chg. Cash for NORTHWEST BIOTHERAPEUTICS INC during this period was $ -228K
  • NORTHWEST BIOTHERAPEUTICS INC reached its highest CF - Chg. Cash over the past 5 years at $ 9.61M.
  • The lowest CF - Chg. Cash recorded by NORTHWEST BIOTHERAPEUTICS INC in the same timeframe $ -8.2M

NORTHWEST BIOTHERAPEUTICS INC's CF - Chg. Cash vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Chg. Cash Benchmarks
CompanyCF - Chg. Cash
RNAC : CARTESIAN THERAPEUTICS INC $ 73.16MINBX : INHIBRX BIOSCIENCES INC $ -40.29MHUMA : HUMACYTE INC $ -5.53MABEO : ABEONA THERAPEUTICS INC $ 129.11MMREO : MEREO BIOPHARMA GROUP PLC $ -33.82MSEPN : SEPTERNA INC $ 58.14MCRDF : CARDIFF ONCOLOGY INC $ -14.72MCATX : PERSPECTIVE THERAPEUTICS INC $ -223.34MBTAI : BIOXCEL THERAPEUTICS INC $ -37.7MADVM : ADVERUM BIOTECHNOLOGIES INC $ -84.9M

Definition of Net Cash Flow - Change in Cash & Cash Equivalents

[Cash Flow Statement] Represents the amount of increase (decrease) in cash and cash equivalents. Includes cash from operations [NCFO], investing [NCFI] and financing [NCFF], adjusted for the effect of exchange rate changes on cash [NCFX]

NWBO - Net Cash Flow - Change in Cash & Cash Equivalents, Last 5 years

$ -8.2M

Minimum

Dec 31, 2022

$ 9.61M

Maximum

Dec 31, 2020

$ 157.4K

Average

$ -228K

Median

CF - Chg. Cash Benchmark Analysis

The chart above depicts the distribution of CF - Chg. Cash for companies in the Total Stock Market. The average CF - Chg. Cash of the companies is $ 1.18M with a standard deviation of $ 44.92M.
The following table provides additional summary stats:
CF - Chg. Cash in the Market:
filtered constituents3.34K
min$ -136.09M
max$ 137.58M
average$ 1.18M
median$ 115.89K
std$ 44.92M